Target Validation Information
TTD ID T55916
Target Name Voltage-gated potassium channel Kv7.4 (KCNQ4)
Type of Target
Literature-reported
Drug Potency against Target Retigabine Drug Info EC50 = 1600 nM [1]
References
REF 1 Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol. 2000 Sep;58(3):591-600.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.